KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jul 30, 2026 - 3:59PM >>  ABB India 7291.95  [ -0.29% ]  ACC 1356.8  [ -0.99% ]  Ambuja Cements 434.3  [ -0.17% ]  Asian Paints 2746.9  [ -0.44% ]  Axis Bank 1228.85  [ -0.57% ]  Bajaj Auto 11434.8  [ 0.92% ]  Bank of Baroda 241.4  [ -0.74% ]  Bharti Airtel 1955.75  [ 0.28% ]  Bharat Heavy 402.85  [ -0.59% ]  Bharat Petroleum 314.75  [ -0.82% ]  Britannia Industries 5535  [ 0.37% ]  Cipla 1464  [ -0.64% ]  Coal India 417.3  [ 1.78% ]  Colgate Palm 2086.9  [ -3.65% ]  Dabur India 425.55  [ -1.82% ]  DLF 656.3  [ -2.10% ]  Dr. Reddy's Lab. 1144.35  [ 0.10% ]  GAIL (India) 173.55  [ -0.94% ]  Grasim Industries 3110.4  [ -0.05% ]  HCL Technologies 1353.2  [ 0.71% ]  HDFC Bank 756.15  [ 1.06% ]  Hero MotoCorp 5325.25  [ 3.48% ]  Hindustan Unilever 2108.05  [ -0.48% ]  Hindalco Industries 969.9  [ 0.80% ]  ICICI Bank 1436.5  [ -0.06% ]  Indian Hotels Co. 746  [ 1.10% ]  IndusInd Bank 1010.8  [ -0.13% ]  Infosys 1156.1  [ 0.05% ]  ITC 285.25  [ -0.30% ]  Jindal Steel 1090  [ 0.09% ]  Kotak Mahindra Bank 388.8  [ -0.38% ]  L&T 3938.45  [ 0.21% ]  Lupin 2422  [ -1.13% ]  Mahi. & Mahi 3278.9  [ 1.73% ]  Maruti Suzuki India 14188.9  [ 1.77% ]  MTNL 26.99  [ -0.95% ]  Nestle India 1520.5  [ 1.44% ]  NIIT 95.3  [ -2.71% ]  NMDC 84.99  [ -1.04% ]  NTPC 344.5  [ 0.29% ]  ONGC 241.6  [ 1.41% ]  Punj. NationlBak 111.6  [ 0.54% ]  Power Grid Corpn. 285.7  [ 1.04% ]  Reliance Industries 1294.4  [ 1.44% ]  SBI 1026.15  [ 1.22% ]  Vedanta 267.6  [ 1.17% ]  Shipping Corpn. 277.35  [ -0.52% ]  Sun Pharmaceutical 2007  [ 0.87% ]  Tata Chemicals 670.3  [ -1.19% ]  Tata Consumer 1094.35  [ -0.23% ]  Tata Motors Passenge 334  [ 1.26% ]  Tata Steel 186.95  [ -0.19% ]  Tata Power Co. 376  [ -0.27% ]  Tata Consult. Serv. 2431.9  [ -0.56% ]  Tech Mahindra 1660.15  [ 0.96% ]  UltraTech Cement 11847.75  [ -1.25% ]  United Spirits 1525.2  [ 1.44% ]  Wipro 186.35  [ 1.53% ]  Zee Entertainment 112.25  [ 3.84% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

AAREY DRUGS & PHARMACEUTICALS LTD.

30 July 2026 | 03:15

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE198H01019 BSE Code / NSE Code 524412 / AAREYDRUGS Book Value (Rs.) 53.02 Face Value 10.00
Bookclosure 30/09/2024 52Week High 100 EPS 1.40 P/E 55.13
Market Cap. 218.67 Cr. 52Week Low 50 P/BV / Div Yield (%) 1.45 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Aarey Drugs & Pharmaceuticals Ltd. (ADPL) was originally incorporated as a private limited company in the name of Niharika Textiles & Chemicals Pvt. Ltd. on 15th May 1990. The Aarey group of companie belonging to the Ghatalia group of companies took over the company and converted it into a public limited company on 18th march 1993. Its name was since changed to Aarey Drugs & Pharmaceuticals Ltd.

The main object of the company is to set up facilities for manufacture of bulk drugs. As an immediate step the company has undertaken a project to manufacture Metronidazole and Metronidazole Benzoate at its works situated at E-34, MIDC Estate.

2008

-Aarey Drugs & Pharmaceuticals Ltd has appointed Mr. Chetan Kiritbhai Mehta as an Independent Director of the Company from June 02, 2008.

2012

-Aarey Drugs & Pharmaceuticals Ltd Issues Rights in the Ratio of 2:1

-Aarey Drugs & Pharmaceuticals has given the Bonus in the Ratio of 1:5

2017 -The company has commenced production of new line of product Mefanamic Acid and has confirmed order for the same from its customers up till October, 2017.